References of "Delanaye, Pierre"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailAnalytical validation of the Liaison Calcitonin_II-Gen (DiaSorin)
Cavalier, Etienne ULg; Carlisi, Ignazia ULg; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry & Laboratory Medicine (2011), 49(2), 271-275

Detailed reference viewed: 21 (1 ULg)
See detailPoints forts de la SFN (Société Française de Néphrologie)
Delanaye, Pierre ULg; Krzesinski, Jean-Marie ULg

Conference (2010, October 10)

Detailed reference viewed: 11 (1 ULg)
Full Text
See detailVascular calcifications in dialysis patients
Delanaye, Pierre ULg; Cavalier, Etienne ULg

Learning material (2010)

Detailed reference viewed: 10 (2 ULg)
Full Text
Peer Reviewed
See detailDosage de la 25-OH vitamine D: attention aux erreurs analytiques!
Cavalier, Etienne ULg; Carlisi, Ignazia ULg; Delanaye, Pierre ULg et al

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 68 (3 ULg)
Full Text
Peer Reviewed
See detailLes cibles thérapeutiques pour la PTH dans les nouvelles recommandations du KDIGO: la fin d'un cauchemar?
Cavalier, Etienne ULg; Jean, G.; Delanaye, Pierre ULg et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 424

Detailed reference viewed: 26 (1 ULg)
Full Text
Peer Reviewed
See detailEvaluation analytique de la cystatine C: résultats de l'étude multicentrique SN/SFBC
Cavalier, Etienne ULg; Barguil, Y.; Bourgeois, A. M. et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 314

Detailed reference viewed: 25 (2 ULg)
Full Text
Peer Reviewed
See detailQuels paramètres cliniques et biologiques peuvent être considérés comme prédictifs des calcifications vasculaires chez le patient hémodialysé?
Delanaye, Pierre ULg; Warling, X.; Moonen, M. et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 296

Detailed reference viewed: 20 (6 ULg)
Full Text
Peer Reviewed
See detailLe dosage urinaire et plasmatique du NGAL: étude analytique et implications pratiques pour le clinicien
Cavalier, Etienne ULg; Rozet, Eric ULg; Bekaert, Anne-Catherine ULg et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 350

Detailed reference viewed: 58 (2 ULg)
Full Text
Peer Reviewed
See detailComparaison d'une méthode "acide" et enzymatique pour le dosage de l'inuline
Thibaudin, L.; Delanaye, Pierre ULg; Maillard, N. et al

in Néphrologie & Thérapeutique (2010, September), 6(5), 316

Detailed reference viewed: 15 (1 ULg)
Full Text
Peer Reviewed
See detailDosage de la vitamine D : attention aux erreurs analytiques!
Cavalier, Etienne ULg; Carlisi, A.; Delanaye, Pierre ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 368

Detailed reference viewed: 31 (4 ULg)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Beckers, Albert ULg

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 214 (5 ULg)
Full Text
Peer Reviewed
See detailDétection précoce de l'hyperparathyroïdie secondaire : impact de l'établissement des valeurs de références de la parathormone
Cavalier, Etienne ULg; Delanaye, Pierre ULg; Beckers, Albert ULg

in 27ème Congrès de la Société Française d'Endocrinologie - Deauville, 29 septembre - 2 octobre 2010 (2010, September)

Detailed reference viewed: 29 (3 ULg)
Full Text
Peer Reviewed
See detailLes anticorps hétérophiles : une cause souvent méconnue d'erreurs de diagnostic
Cavalier, Etienne ULg; Carlisi, A.; Delanaye, Pierre ULg et al

in Annales d'Endocrinologie (2010, September), 71(5), 367-68

Detailed reference viewed: 13 (0 ULg)
Full Text
Peer Reviewed
See detailThe Ratio of Parathyroid Hormone as Measured by Third- and Second-Generation Assays as a Marker for Parathyroid Carcinoma.
Cavalier, Etienne ULg; Daly, Adrian ULg; Betea, Daniela ULg et al

in Journal of Clinical Endocrinology and Metabolism (2010), 95

Background: Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is ... [more ▼]

Background: Parathyroid carcinoma (PCa) is a rare disease that can be difficult to differentiate initially from severe benign parathyroid adenoma. PCa oversecrete the amino form of PTH, which is recognized by third-generation but not by second-generation PTH immunoassays. In normal individuals, the third-generation to second-generation PTH ratio should be less than 1. Objective: Our objective was to study the utility of the third-generation to second-generation PTH ratio as a means of distinguishing PCa patients (n = 24) from control groups with and without disorders of calcium secretion, including patients on renal hemodialysis (n = 74), postrenal transplantation (n = 60), and primary hyperparathyroidism (PHP; n = 30). Setting and Design: We conducted a retrospective, laboratory-based study at tertiary referral academic centers. Results: The mean third-generation to second-generation ratio was 0.58 ± 0.10 in the dialysis patients, 0.54 ± 0.10 in the renal transplant group, 0.54 ± 0.12 in the elderly healthy patients, and 0.68 ± 0.11 in the PHP group. All 245 of these patients presented a PTH third-generation to second-generation ratio of less than 1. In contrast, we observed an inverted third-generation to second-generation PTH ratio of more than one in 20 PCa patients, whereas only four PCa patients had a normal ratio of less than 1. Conclusions: An inverted third-generation to second-generation PTH ratio occurred in the majority of patients with advanced PCa and was absent in all 245 relevant controls. A third-generation to second-generation PTH ratio higher than 1 had a sensitivity of 83.3% and a specificity of 100% among PHP patients as a marker for PCa. This ratio may be useful to identify patients with PCa earlier and to detect patients either at risk of developing PCa or those in whom recurrence is taking place. [less ▲]

Detailed reference viewed: 56 (9 ULg)
Full Text
Peer Reviewed
See detailEvaluation of Liaison Calcitonin II Gen, a new kit for Calcitonin determination
Cavalier, Etienne ULg; Carlisi, Ignazia ULg; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry (2010, June), 56(S6), 188

Detailed reference viewed: 39 (2 ULg)
Full Text
Peer Reviewed
See detailAnalytical validation of the Abbott Architect urine NGAL
Cavalier, Etienne ULg; Saarbach, D.; Bekaert, Anne-Catherine ULg et al

in Clinical Chemistry (2010, June), 56(S6), 96

Detailed reference viewed: 71 (2 ULg)